Vertex v. Lupin: Prosecution History Estoppel Closes the Gap Between 80% and 74%
A case note on the District of Delaware’s August 24, 2026 memorandum opinion holding that Lupin’s ~74% ivacaftor generic does […]
A case note on the District of Delaware’s August 24, 2026 memorandum opinion holding that Lupin’s ~74% ivacaftor generic does […]
A case note on the D.C. Circuit’s August 25, 2026 decision affirming in part and reversing in part the FDA’s